Hypertension Clinical Trials

Showing 701-720 of 3,009 trials

Empagliflozin in Pulmonary Arterial Hypertension

NCT05493371

The aim of the study is to determine whether conducting a randomized placebo-controlled clinical trial is feasible, safe for the patient and whether the treatment is well tolerated in patients with idiopathic pulmonary arterial hypertension.

Idiopathic Pulmonary Arterial Hypertension

Amsterdam UMC, location VUmc8 participantsStarted Mar 2023

Amsterdam, North Holland, Netherlands

COMPLETEDPhase 2

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

NCT03541603

Phase 2 study to evaluate the efficacy and safety of intermittent levosimendan compared with placebo in hemodynamic improvement with exercise in PH-HFpEF subjects

Hypertension Pulmonary SecondaryHeart Failure, Right SidedHeart Failure With Normal Ejection Fraction

Tenax Therapeutics, Inc.44 participantsStarted Nov 2018

Stanford, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +13 more locations

Empagliflozin in Pulmonary Arterial Hypertension

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Related Searches

Dietary Approaches to Stop Hypertension for Diabetes

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

Pulmonary Artery Doppler And Neonatal Outcome In Hypertensive Disorders Of Pregnancy

Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study

High Potassium Diet with Spices and Herbs As Salt Substitute for Lowering Blood Pressure in Older Adults: Study Protocol

Effect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During Induction of General Anesthesia

Acute Effect of Photobiomodulation in Individuals with Hypertension

Echocardiographic Analysis by Artificial Intelligence in Hypertension

Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety

Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts

Evaluation of Physical Fitness and Hemodynamics Across a Diverse Population

EVALUATION of CATS TONOMETER PRISM in LASIK SUBJECTS

Quest to Analyze One Thousand Humans Meditating

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso

Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients

Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini

Positive Care Effect of the Digital Health Assistant ADELE Blood Pressure for Hypertension Patients